| Literature DB >> 28107412 |
Daniel Eibach1, Michael Nagel2, Benedikt Hogan1,3, Clinton Azuure4, Ralf Krumkamp1,3, Denise Dekker1,3, Mike Gajdiss5, Melanie Brunke6, Nimako Sarpong3, Ellis Owusu-Dabo4, Jürgen May1,3.
Abstract
BACKGROUND: Nasal carriage with Staphylococcus aureus is a common risk factor for invasive infections, indicating the necessity to monitor prevalent strains, particularly in the vulnerable paediatric population. This surveillance study aims to identify carriage rates, subtypes, antimicrobial susceptibilities and virulence markers of nasal S. aureus isolates collected from children living in the Ashanti region of Ghana.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28107412 PMCID: PMC5249101 DOI: 10.1371/journal.pone.0170320
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic characteristics of study participants.
| Characteristics | Total (%) | non- | |
|---|---|---|---|
| (N = 544) | (N = 120) | (N = 424) | |
| Sex, female (%) | 255 (46.9) | 61 (50.8) | 194 (45.8) |
| Age, median months (IQR) | 32 (17–60) | 41 (24–78) | 29 (15–52) |
IQR, interquartile range.
Fig 1Age and sex distribution of spa-types.
Distribution of spa-types (n = 123) and nasal Staphylococcus aureus prevalence by 2-years age-groups and sex (n = 544). Girls (continuous line) are colonized when they are approximately 2 years younger than boys (dashed line).
Characterization of nasal Staphylococcus aureus isolates (n = 123).
| CC | ST | MRSA [n(%)] | MDR [n(%)] | PVL [n(%)] | TSST [n(%)] | |
|---|---|---|---|---|---|---|
| CC1 | ST1 | t127 (3), t591 (1) | 0 (0.0) | 0 (0.0) | 2 (66.7) | 2 (66.7) |
| ST72 | t537 (2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (50.0) | |
| CC121 | ST121 | t311 (9), t314 (7), t645 (1), t1114 (2) | 0 (0.0) | 3 (15.8) | 13 (68.4) | 2 (10.5) |
| CC15 | ST15 | t84 (18), t085 (1), t346 (1), t385 (1) | 0 (0.0) | 2 (9.5) | 14 (66.7) | 3 (14.3) |
| CC152 | ST152 | t1096 (3), t355 (25), t1123 (2), t1172 (1), t1299 (4) | 1 (2.9) | 7 (20.0) | 30 (85.7) | 3 (8.6) |
| ST377 | t5047 (1) | 0 (0.0) | 0 (0.0) | 1 (100.0) | 0 (0.0) | |
| CC30 | ST30 | t318 (1), t363 (3), t2147 (1) | 0 (0.0) | 0 (0.0) | 4 (80.0) | 0 (0.0) |
| ST30, ST33, ST55 | t21 (1) | 0 (0.0) | 1 (100.0) | 0 (0.0) | 0 (0.0) | |
| CC45 | ST45 | t939 (13), t157 (1), t4454 (5) | 1 (5.3) | 1 (5.3) | 3 (15.8) | 1 (5.3) |
| CC508 | ST508 | t15727 (1), t1510 (1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (100.0) |
| CC5 | ST5 | t450 (1) | 0 (0.0) | 1 (100.0) | 0 (0.0) | 0 (0.0) |
| CC707 | ST707 | t15728 (1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (100.0) |
| CC8 | ST8 | t8 (3), t1476 (1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| ST18 | t451 (1) | 0 (0.0) | 1 (100.0) | 1 (100.0) | 0 (0.0) | |
| CC88 | ST88 | t186 (1), t4104 (2) | 0 (0.0) | 0 (0.0) | 3 (100.0) | 0 (0.0) |
| singleton | ST3248 | t6063 (2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (100.0) |
| singleton | ST944 | t616 (2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
CC: Clonal Complex; ST: Sequence Type; MRSA: Methicillin-resistant Staphylococcus aureus; MDR: Multidrug resistant; PVL: Panton-Valentine leukocidin; TSST: Toxic shock syndrome toxin.
Fig 2Temporal distribution of spa-types.
Distribution of spa-types (n = 123) by month. The black line indicates the Staphylococcus aureus prevalence (n = 544).
Antibiotic resistance profile of nasal Staphylococcus aureus isolates (n = 123).
| Antibiotic | Resistance [n (%)] | |
|---|---|---|
| Penicillin | 117 | (95.1) |
| Tetracycline | 66 | (53.7) |
| Erythromycin | 14 | (11.4) |
| Clindamycin | 7 | (5.7) |
| Trimethoprim-sulfamethoxazole | 4 | (3.3) |
| Gentamicin | 3 | (2.4) |
| Cefoxitin | 2 | (1.6) |
| Ciproflocacin | 2 | (1.6) |
| Linezolid | 0 | (0.0) |
| Tigecycline | 0 | (0.0) |
| Vancomycin | 0 | (0.0) |
| Multidrug resistance | 16 | (13.0) |
§ Resistance to three or more antimicrobial classes.